Cohn EJ, Strong LE, Hughes WL, et al. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 1946;68:459–75.CohnEJStrongLEHughesWL, Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc1946;68:459–75.10.1021/ja01207a03421015743Search in Google Scholar
Oncley JL, Melin M, Richert DA, et al. The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and β1-lipoprotein into subfractions of human plasma. J Am Chem Soc 1949;71:541–50.OncleyJLMelinMRichertDA, The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and β1-lipoprotein into subfractions of human plasma. J Am Chem Soc1949;71:541–50.10.1021/ja01170a04818112064Search in Google Scholar
U.S. Food and Drug Administration. Source Plasma. Code of Federal Regulations 21, Section 640, Subpart G (2018). Available from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm.U.S. Food and Drug Administration. Source Plasma. Code of Federal Regulations 21, Section 640, Subpart G (2018). Available from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm.Search in Google Scholar
Brorson K, Campbell J, Carter J, et al. Virus Filtration Technical Report No. 41. PDA J Pharm Sci Technol 2008;62:S-4.BrorsonKCampbellJCarterJ, Virus Filtration Technical Report No. 41. PDA J Pharm Sci Technol2008;62:S-4.Search in Google Scholar
Dichtelmüller HO, Biesert L, Fabbrizzi F, et al. Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion 2009;49:1931–43.DichtelmüllerHOBiesertLFabbrizziF, Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion2009;49:1931–43.10.1111/j.1537-2995.2009.02222.x718778019497061Search in Google Scholar
Morgenthaler JJ. Securing viral safety for plasma derivatives. Transfus Med Rev 2001;15:224–33.MorgenthalerJJ.Securing viral safety for plasma derivatives. Transfus Med Rev2001;15:224–33.10.1053/tmrv.2001.2459011471124Search in Google Scholar
Thorpe SL, Sands D, Fox B, et al. A global standard for anti-D immunoglobulin: international collaborative study to evaluate a candidate preparation. Vox Sang 2003;85:313–21.ThorpeSLSandsDFoxB, A global standard for anti-D immunoglobulin: international collaborative study to evaluate a candidate preparation. Vox Sang2003;85:313–21.10.1111/j.0042-9007.2003.00367.x14633258Search in Google Scholar
Berry D, DiGuardo M, Mo YD, Wehrli G. Anti-D from alloimmunization versus RhIG: detective work in the blood bank and transfusion medicine services. Transfusion 2018;58:2490–4.BerryDDiGuardoMMoYDWehrliG.Anti-D from alloimmunization versus RhIG: detective work in the blood bank and transfusion medicine services. Transfusion2018;58:2490–4.10.1111/trf.1487230230552Search in Google Scholar
Hannon JL, Clarke G. Laboratory management of perinatal patients with apparently “new” anti-D. Immunohematology 2016;32:108–11.HannonJLClarkeG.Laboratory management of perinatal patients with apparently “new” anti-D. Immunohematology2016;32:108–11.10.21307/immunohematology-2019-055Search in Google Scholar
Sandler SG, Gottschall JL. Postpartum Rh immunoprophylaxis. Obstet Gynecol 2012;120:1428–38.SandlerSGGottschallJL.Postpartum Rh immunoprophylaxis. Obstet Gynecol2012;120:1428–38.10.1097/AOG.0b013e3182742ebaSearch in Google Scholar
American College of Obstetrics and Gynecology. ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. Int J Gynecol Obstet 1999;66:63–70.American College of Obstetrics and Gynecology. ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. Int J Gynecol Obstet1999;66:63–70.Search in Google Scholar
Hartwell EA. Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol 1998;110:281–92.HartwellEA.Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol1998;110:281–92.10.1093/ajcp/110.3.2819728602Search in Google Scholar
Sandler SG, Sathiyamoorthy S. Laboratory methods for detecting fetomaternal hemorrhage. Immunohematology 2010;26:92–103.SandlerSGSathiyamoorthyS.Laboratory methods for detecting fetomaternal hemorrhage. Immunohematology2010;26:92–103.Search in Google Scholar
Sandler SG, Delaney M, Gottschall JL, for the CAP Transfusion Medicine Resource Committee. Proficiency tests reveal the need to improve laboratory assays for fetomaternal hemorrhage for Rh immunoprophylaxis. Transfusion 2013;53:2098–102.SandlerSGDelaneyMGottschallJLfor the CAP Transfusion Medicine Resource Committee. Proficiency tests reveal the need to improve laboratory assays for fetomaternal hemorrhage for Rh immunoprophylaxis. Transfusion2013;53:2098–102.10.1111/trf.1213023445376Search in Google Scholar
Fung MK, Eder AE, Spitalnik SL, Westhoff CM, Eds. Technical manual. 19th ed. Bethesda, MD: AABB, 2017:604.FungMKEderAESpitalnikSLWesthoffCM, Eds. Technical manual. 19th ed.Bethesda, MD: AABB, 2017:604.Search in Google Scholar
Moise KJ, Gandhi M, Boring NH, et al. Circulating cell-free DNA to determine the fetal RHD status in all three trimesters of pregnancy. Obstet Gynecol 2016;128:1340–6.MoiseKJGandhiMBoringNH, Circulating cell-free DNA to determine the fetal RHD status in all three trimesters of pregnancy. Obstet Gynecol2016;128:1340–6.10.1097/AOG.0000000000001741Search in Google Scholar
Zhu YJ, Zheng YR, Li L, et al. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free DNA: a meta analysis. J Matern Fetal Neonatal Med 2014;27:1839–44.ZhuYJZhengYRLiL, Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free DNA: a meta analysis. J Matern Fetal Neonatal Med2014;27:1839–44.10.3109/14767058.2014.882306Search in Google Scholar
Kent J, Farrell AM, Soothill P. Routine administration of anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice. BMC Pregnancy Childbirth 2014;14:87.KentJFarrellAMSoothillP.Routine administration of anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice. BMC Pregnancy Childbirth2014;14:87.10.1186/1471-2393-14-87Search in Google Scholar
de Haas M, Thurik FF, van der Ploeg CPV, et al. Sensitivity of fetal RHD screening for safe guidance or targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands. BMJ 2016;355:i1589.de HaasMThurikFFvan der PloegCPV, Sensitivity of fetal RHD screening for safe guidance or targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands. BMJ2016;355:i1589.10.1136/bmj.i5789Search in Google Scholar
Kennedy MS, McNanie, Waheed A. Detection of ante-D following antepartum injections of Rh immune globulin. Immunohematology 1998;14:138–40.KennedyMSMcNanie, WaheedA.Detection of ante-D following antepartum injections of Rh immune globulin. Immunohematology1998;14:138–40.10.21307/immunohematology-2019-681Search in Google Scholar
Lee D, Contreras M, Robson SC, et al. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynecologists. Transfus Med 1999;9:93–7.LeeDContrerasMRobsonSC, Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynecologists. Transfus Med1999;9:93–7.10.1046/j.1365-3148.1999.009001093.xSearch in Google Scholar
Pollack W, Ascari WQ, Crispen JF, et al. Studies on Rh prophylaxis II. Rh immune prophylaxis after transfusion with Rh-positive blood. Transfusion 1971;11:340–4.PollackWAscariWQCrispenJF, Studies on Rh prophylaxis II. Rh immune prophylaxis after transfusion with Rh-positive blood. Transfusion1971;11:340–4.10.1111/j.1537-2995.1971.tb04425.xSearch in Google Scholar
Bowman HS, Mohn JF, Lambert R. Prevention of maternal immunization after accidental transfusion of D(Rho)-positive blood. Vox Sang 1972;22:385–96.BowmanHSMohnJFLambertR.Prevention of maternal immunization after accidental transfusion of D(Rho)-positive blood. Vox Sang1972;22:385–96.Search in Google Scholar
Goldfinger D, McGinniss MH. Rh-incompatible platelet transfusions: risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971;284:942–4.GoldfingerDMcGinnissMH.Rh-incompatible platelet transfusions: risks and consequences of sensitizing immunosuppressed patients. N Engl J Med1971;284:942–4.10.1056/NEJM197104292841704Search in Google Scholar
McGinniss MH, Bronson WR, Freireich E, Kliman A. Formation of red cell antibodies in response to platelet transfusions (abstract). Transfusion 1963;3:426.McGinnissMHBronsonWRFreireichEKlimanA.Formation of red cell antibodies in response to platelet transfusions (abstract). Transfusion1963;3:426.Search in Google Scholar
Cid J, Yazer MH, Lozano M, et al. Platelet transfusion and respecting patient D type. Curr Opion Hematol 2015;22:540–6.CidJYazerMHLozanoM, Platelet transfusion and respecting patient D type. Curr Opion Hematol2015;22:540–6.10.1097/MOH.0000000000000185Search in Google Scholar
Anderson B, Shad AT, Gootenberg JE, Sandler SG. Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD). Am J Hematol 1999;60:245–7.AndersonBShadATGootenbergJESandlerSG.Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD). Am J Hematol1999;60:245–7.10.1002/(SICI)1096-8652(199903)60:3<245::AID-AJH16>3.0.CO;2-4Search in Google Scholar
Ewing CA, Rumsey DH, Langeberg AF, Sandler SG. Immunoprophylaxis using intravenous Rh immune globulin should be standard practice when selected D-negative platelets are transfused with D-positive random donor platelets. Immunohematology 1998;14:133–7.EwingCARumseyDHLangebergAFSandlerSG.Immunoprophylaxis using intravenous Rh immune globulin should be standard practice when selected D-negative platelets are transfused with D-positive random donor platelets. Immunohematology1998;14:133–7.10.21307/immunohematology-2019-680Search in Google Scholar
Savasman CM, Sandler SG. Serologic aspects of treating immune thrombocytopenic purpura using intravenous immune globulin. Immunohematology 2001;17:106–10.SavasmanCMSandlerSG.Serologic aspects of treating immune thrombocytopenic purpura using intravenous immune globulin. Immunohematology2001;17:106–10.10.21307/immunohematology-2019-562Search in Google Scholar
Sandler SG. Intravenous immune globulin for treating immune thrombocytopenic purpura. Current Opin Hematol 2001;8:417–20.SandlerSG.Intravenous immune globulin for treating immune thrombocytopenic purpura. Current Opin Hematol2001;8:417–20.10.1097/00062752-200111000-0001711604585Search in Google Scholar
Sandler SG. Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using Intravenous Rho (D) immune globulin. Transfus Med Rev 2001;15:67–76.SandlerSG.Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using Intravenous Rho (D) immune globulin. Transfus Med Rev2001;15:67–76.10.1053/tmrv.2001.1995311149979Search in Google Scholar
Sandler SG, Tutuncuoglu SO. Immune thrombocytopenic purpura: current management practices. Expert Opin Pharmacother 2004;5:2515–27.SandlerSGTutuncuogluSO.Immune thrombocytopenic purpura: current management practices. Expert Opin Pharmacother2004;5:2515–27.10.1517/14656566.5.12.251515571469Search in Google Scholar
Sandler SG. Review: immune thrombocytopenic purpura: an update for immunohematologists. Immunohematology 2004;20:112–7.SandlerSG.Review: immune thrombocytopenic purpura: an update for immunohematologists. Immunohematology2004;20:112–7.10.21307/immunohematology-2019-432Search in Google Scholar
Mikesell KV, George MR, Castellani WJ, et al. Evaluation of different testing methods for identification of RhIG in red blood cell antibody detection. Transfusion 2015;55:1444–50.MikesellKVGeorgeMRCastellaniWJ, Evaluation of different testing methods for identification of RhIG in red blood cell antibody detection. Transfusion2015;55:1444–50.10.1111/trf.1301825648788Search in Google Scholar
Weisbach V, Kohnhauser T, Zimmermann R, et al. Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies. Transfus Med 2006;16:276–84.WeisbachVKohnhauserTZimmermannR, Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies. Transfus Med2006;16:276–84.10.1111/j.1365-3148.2006.00674.x16879156Search in Google Scholar
Delaflor-Weiss E, Chizhevsky V. Implementation of gel testing for antibody screening and identification in a community based hospital, a 3 year experience. Lab Med 2005;8:489–92.Delaflor-WeissEChizhevskyV.Implementation of gel testing for antibody screening and identification in a community based hospital, a 3 year experience. Lab Med2005;8:489–92.10.1309/JAP6EC69BAAUG9B3Search in Google Scholar
National Blood Authority. Guidelines on the prophylactic use of Rh D immunoglobulin (anti-D) in obstetrics. 2003. Available from www.blood.gov.au/system/files/documents/glines-anti-d.pdf.National Blood Authority. Guidelines on the prophylactic use of Rh D immunoglobulin (anti-D) in obstetrics. 2003. Available from www.blood.gov.au/system/files/documents/glines-anti-d.pdf.Search in Google Scholar
Australian and New Zealand Society of Blood Transfusion Ltd. Guidelines for blood grouping & antibody screening in the antenatal and perinatal setting. 3rd ed. 2007. Available from www.seqirus.com.au/docs/471/745/ANGuidelines_2007[1].pdf.Australian and New Zealand Society of Blood Transfusion Ltd.Guidelines for blood grouping & antibody screening in the antenatal and perinatal setting. 3rd ed.2007. Available from www.seqirus.com.au/docs/471/745/ANGuidelines_2007[1].pdf.Search in Google Scholar
White J, Qureshi H, Massey E, et al. Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med 2016;26:246–63.WhiteJQureshiHMasseyE, Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med2016;26:246–63.10.1111/tme.1229927074872Search in Google Scholar
Qureshi H, Massey E, Kirwan D, et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med 2014;24:8–20.QureshiHMasseyEKirwanD, BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med2014;24:8–20.10.1111/tme.1209125121158Search in Google Scholar
Szkotak AJ, Lunty B, Nahirniak S, Clarke G. Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis. Vox Sang 2016;110:51–9.SzkotakAJLuntyBNahirniakSClarkeG.Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis. Vox Sang2016;110:51–9.10.1111/vox.1230226031621Search in Google Scholar
Irving C, Crennan M, Vanniasinkam T. Can serological methods help distinguish between prophylactic and alloimmune anti-D? Transfus Med 2017;27:362–8.IrvingCCrennanMVanniasinkamT.Can serological methods help distinguish between prophylactic and alloimmune anti-D?Transfus Med2017;27:362–8.10.1111/tme.1242028508562Search in Google Scholar
Rushin J, Rumsey DH, Ewing CA, Sandler SG. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin. Transfusion 2000;40:551–4.RushinJRumseyDHEwingCASandlerSG.Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin. Transfusion2000;40:551–4.10.1046/j.1537-2995.2000.40050551.x10827257Search in Google Scholar
